Annika Auranen - Concepedia

Author

Annika Auranen

Also Known As

A Auranen, A. AURANEN, A. Auranen, ANNIKA AURANEN, Airi Jussila, Andrew Peterson, Anne Remes, Annika Auranen, Audrey Chu, Auranen

148

Publications

Citations

H-Index

Concepts

All Affiliations

Turku University Hospital Tampere University Hospital University of Turku University of Helsinki

About

Annika Auranen is an author at Turku University Hospital specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	884
2	Health Sciences	4	4	340
3	Public Health	3	3	125
4	Cell Biology	2	2	45
5	Engineering	1	1	38

Annika Auranen

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, New England Journal of Medicine	2023	718
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Kaisa Huhtinen, Pia Suvitie, Jukka Hiissa, British Journal of Cancer	2009	291
Polymorphisms in DNA repair genes and epithelial ovarian cancer risk Annika Auranen, Honglin Song, Christy Waterfall, International Journal of Cancer	2005	150
Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy Jaakko Tyrmi, Tea Kaartokallio, A. Inkeri Lokki, JAMA Cardiology	2023	114
A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer Johanna Hynninen, Jukka Kemppainen, Maija Lavonius, Gynecologic Oncology Positron Emission TomographyHealth SciencesMedical ImagingMedicinePet-mri	2013	102
Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Johanna Hynninen, Maija Lavonius, Sinikka Oksa, Gynecologic Oncology Intra-abdominal Tumor SpreadSurgical OncologyOvarian Cancer SurgeryNeoadjuvant ChemotherapyMedical Imaging	2012	101
FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread Johanna Hynninen, Annika Auranen, Olli Carpén, Gynecologic Oncology Fdg Pet/ctTumoral PathologyHealth SciencesTraditional PatternOncologic Imaging	2012	95
LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial Mansoor Raza Mirza, Line Bjørge, Frederik Marmé, Annals of Oncology Endocrine-related CancerMedicinePharmacologyGynecologyPharmacotherapy	2020	81
Cancer incidence in the first-degree relatives of ovarian cancer patients Annika Auranen, Eero Pukkala, Juuso Mäkinen, British Journal of Cancer Cancer EpidemiologyEndocrine-related CancerMedicineEpidemiology Of CancerGynecology	1996	59
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer Tuulia Vallius, Johanna Hynninen, Annika Auranen, Tumor Biology	2014	55

Page 1